Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-8,805
Closed -$329K 796
2018
Q1
$329K Sell
8,805
-266
-3% -$10.7K 0.01% 598
2017
Q4
$388K Sell
9,071
-2,106
-19% -$84K 0.01% 558
2017
Q3
$410K Sell
11,177
-4,001
-26% -$161K 0.01% 520
2017
Q2
$689K Buy
15,178
+2,467
+19% +$109K 0.03% 398
2017
Q1
$541K Buy
12,711
+1,980
+18% +$80.7K 0.02% 422
2016
Q4
$431K Buy
10,731
+3,622
+51% +$140K 0.02% 425
2016
Q3
$276K Buy
+7,109
New +$268K 0.01% 465

Other funds holding HOLX

ETrade Capital Management's HOLX Position: Q2 2018 in Review

ETrade Capital Management sold out of Hologic (HOLX) in Q2 2018, closing a stake of 8,805 shares — an estimated $329K sold.

ETrade Capital Management first reported a position in HOLX in Q3 2016 and held it in 7 quarters. The position peaked at $689K in Q2 2017. 450 funds tracked by Wall St. Rank hold HOLX as of Q2 2018.

  • ETrade Capital Management reported no remaining Hologic position as of Q2 2018 after selling out during the quarter.
  • ETrade Capital Management sold 8,805 Hologic shares in Q2 2018, an estimated $329K.
  • ETrade Capital Management first reported a position in Hologic in Q3 2016 and held it in 7 quarters.
  • ETrade Capital Management's Hologic position peaked at $689K in Q2 2017.
  • 450 funds tracked by Wall St. Rank held Hologic as of Q2 2018.

Based on ETrade Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.